SUZHOU, China

Shihe Liang

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Ascentage Pharma (Suzhou) Co., Ltd., Ascentage Pharma Group Corp Limited, Guangzhou Healthquest Pharma Co., Ltd.. Active years: 2024.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Inventor Shihe Liang

Introduction

Shihe Liang is a prominent inventor based in Suzhou, China. He has made significant contributions to the field of pharmaceuticals, specifically in the development of innovative compositions that enhance drug efficacy.

Latest Patents

Liang holds a patent for a pharmaceutical composition containing an alkynyl compound, detailing a preparation method and its various applications. This patent emphasizes the inclusion of the active pharmaceutical ingredient 3-((1H-pyrazolo[3,4-b]pyridin-5-yl)ethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-benzamide, alongside acceptable pharmaceutical excipients such as diluents and lubricants. His formulation aims to improve the bioavailability, dissolution, and stability of the alkynyl compound, thereby enhancing drug safety.

Career Highlights

Throughout his career, Shihe Liang has been affiliated with notable companies in the pharmaceutical sector, including Ascentage Pharma (Suzhou) Co., Ltd. and Ascentage Pharma Group Corp Limited. His work in these organizations has underscored his commitment to research and development in the pharmaceutical field.

Collaborations

Liang has collaborated with esteemed colleagues such as Yanqiong Lin and Jianfeng Wen. Together, they have worked towards advancing pharmaceutical formulations and improving therapeutic outcomes.

Conclusion

Shihe Liang’s inventive contributions, particularly in the area of pharmaceutical compositions, showcase his dedication to enhancing drug effectiveness and safety. His ongoing work and collaborations continue to impact the pharmaceutical industry positively, paving the way for future innovations.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…